I am not sure of this... it was probably a while a
Post# of 148164
I am sure if I remember this Nader statement correctly that a conformational trial for this new dosage with RO would have to be completed to gather the efficacy. I believe they we seeing longer Receptor Occupancy with the new RO lab testing.
Does anyone else remember this?
Maybe it doesn’t apply to Covid?